AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33555697 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Avoidance Test‐Back Pain (BAT‐Back) score >22
Number of subjects: 43
Study 35299177 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus paclitaxel
Number of subjects: 0
Study 35299177 — intervention group
Group type: COMPARATOR
Intervention: Site-specific therapy based on gene expression profiling (GEP)
Number of subjects: 0
Study 35299177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 32114531 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 286
Study 32114531 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 286
Study 35751858 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 0
Study 35751858 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 0
Study 32205375 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack intervention (software for smart devices and coaching support)
Number of subjects: 12
Study 35595223 — intervention group
Group type: COMPARATOR
Intervention: hCG alone (6000 IU)
Number of subjects: 510
Study 35595223 — intervention group
Group type: COMPARATOR
Intervention: GnRHa alone (0.2 mg of triptorelin)
Number of subjects: 510
Study 35595223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual trigger (0.2 mg of triptorelin plus 2000 IU of hCG)
Number of subjects: 510
Study 34735862 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted education on the use of oral HIV self-test kits for their partners, along with up to five oral HIV self-test kits.
Number of subjects: 326
Study 34735862 — intervention group
Group type: COMPARATOR
Intervention: Control group received partner notification services only.
Number of subjects: 326
Study 34674160 — intervention group
Group type: EXPERIMENTAL
Intervention: IDP-126 (clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15%)
Number of subjects: 741
Study 34674160 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 741
Study 34674160 — intervention group
Group type: COMPARATOR
Intervention: BPO/adapalene
Number of subjects: 741
Study 34674160 — intervention group
Group type: COMPARATOR
Intervention: clindamycin phosphate/BPO
Number of subjects: 741
Study 34674160 — intervention group
Group type: COMPARATOR
Intervention: clindamycin phosphate/adapalene
Number of subjects: 741
Study 34674160 — intervention group
Group type: EXPERIMENTAL
Intervention: IDP-126
Number of subjects: 741
Study 34674160 — intervention group
Group type: COMPARATOR
Intervention: Vehicle or dyads
Number of subjects: 741
Study 32220260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal Ethanol (ET)
Number of subjects: 80
Study 32220260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal Sodium Pentobarbital (PB)
Number of subjects: 80
Study 32220260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal Sodium Pentobarbital (PB) with anesthesia
Number of subjects: 80
Study 32220260 — intervention group
Group type: COMPARATOR
Intervention: Intrahepatic Sodium Pentobarbital (PB)
Number of subjects: 80
Study 35341337 — intervention group
Group type: EXPERIMENTAL
Intervention: Home phototherapy
Number of subjects: 8
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin)
Number of subjects: 90
Study 32430507 — intervention group
Group type: COMPARATOR
Intervention: EPOCH-vorinostat (EPOCH plus 300 mg vorinostat on days 1 to 5 of each cycle)
Number of subjects: 90
Study 32430507 — intervention group
Group type: COMPARATOR
Intervention: EPOCH-vorinostat
Number of subjects: 90
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: EPOCH
Number of subjects: 90
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Myc+ DLBCL
Number of subjects: 90
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CD4+ count <200 cells/mm3
Number of subjects: 90
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: Low diagnosis-to-treatment interval (DTI)
Number of subjects: 90
Study 32430507 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprotocol therapy
Number of subjects: 90
Study 35983429 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine (1.5 mg kg−1 followed by 4 mg kg−1 h−1 continuous infusion)
Number of subjects: 140
Study 35983429 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine
Number of subjects: 140
Study 34759182 — intervention group
Group type: EXPERIMENTAL
Intervention: High-molecular-weight hyaluronate injection (20 mg)
Number of subjects: 79
Study 34759182 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hyaluronate injection (20 mg)
Number of subjects: 79
Study 34759182 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (10 sessions)
Number of subjects: 79
Study 33141096 — intervention group
Group type: EXPERIMENTAL
Intervention: LungTalk - a web-based tailored computer program (n=31)
Number of subjects: 60
Study 33141096 — intervention group
Group type: COMPARATOR
Intervention: Generic information about lung cancer screening from the American Cancer Society (n=29)
Number of subjects: 60
Study 33141096 — intervention group
Group type: EXPERIMENTAL
Intervention: LungTalk
Number of subjects: 60
Study 35712892 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible take-home dosing buprenorphine/naloxone
Number of subjects: 269
Study 35712892 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised methadone models of care
Number of subjects: 269
Study 32054507 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianzhi granule (TZ)
Number of subjects: 543
Study 32054507 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 543
Study 32054507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 543
Study 35276813 — intervention group
Group type: EXPERIMENTAL
Intervention: ONE: 45 min/d continuous brisk walking bout
Number of subjects: 19
Study 35276813 — intervention group
Group type: EXPERIMENTAL
Intervention: MICRO: 5 min brisk walking each hour for 9 h
Number of subjects: 19
Study 35276813 — intervention group
Group type: COMPARATOR
Intervention: SED: Sedentary control
Number of subjects: 19
Study 35276813 — intervention group
Group type: EXPERIMENTAL
Intervention: ONE and MICRO
Number of subjects: 19
Study 35276813 — intervention group
Group type: EXPERIMENTAL
Intervention: ONE
Number of subjects: 19
Study 33040362 — intervention group
Group type: EXPERIMENTAL
Intervention: Early egg introduction
Number of subjects: 206
Study 33040362 — intervention group
Group type: COMPARATOR
Intervention: No early egg introduction
Number of subjects: 206
Study 32727601 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care counselling
Number of subjects: 76
Study 32727601 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 76
Study 35617287 — intervention group
Group type: COMPARATOR
Intervention: Early mobilization (EM)
Number of subjects: 150
Study 35617287 — intervention group
Group type: COMPARATOR
Intervention: Early mobilization combined with early nutrition (EMN)
Number of subjects: 150
Study 35617287 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care (Control)
Number of subjects: 150
Study 34789316 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee instability (KI) group (n=26)
Number of subjects: 57
Study 34789316 — intervention group
Group type: COMPARATOR
Intervention: No knee instability group (n=31)
Number of subjects: 57
Study 34377358 — intervention group
Group type: EXPERIMENTAL
Intervention: PM+ with care-as-usual (CAU)
Number of subjects: 90
Study 34377358 — intervention group
Group type: EXPERIMENTAL
Intervention: PM+ with Emotional Processing (PM+EP) with CAU
Number of subjects: 90
Study 34377358 — intervention group
Group type: COMPARATOR
Intervention: CAU only
Number of subjects: 90
Study 36414833 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus energy restriction (EXER)
Number of subjects: 60
Study 36414833 — intervention group
Group type: COMPARATOR
Intervention: Energy restriction only (ER)
Number of subjects: 60
Study 32691178 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methadone (LDM)
Number of subjects: 30
Study 36046452 — intervention group
Group type: EXPERIMENTAL
Intervention: GA+SA
Number of subjects: 50
Study 34938043 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (BTX)
Number of subjects: 42
Study 34938043 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional occlusal stents
Number of subjects: 42
Study 34938043 — intervention group
Group type: COMPARATOR
Intervention: Control group (removal of OD at night)
Number of subjects: 42
Study 36483295 — intervention group
Group type: EXPERIMENTAL
Intervention: NESA neuromodulation treatment (NNT)
Number of subjects: 12
Study 36483295 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 32282852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 967
Study 32282852 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1,700 mg/day
Number of subjects: 967
Study 32282852 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg/day
Number of subjects: 967
Study 32282852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of linagliptin/metformin
Number of subjects: 967
Study 36035839 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based teaching method based on primary teaching principle
Number of subjects: 126
Study 36035839 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching approach
Number of subjects: 126
Study 32932369 — intervention group
Group type: EXPERIMENTAL
Intervention: TECNIS Eyhance IOL (Model ICB00)
Number of subjects: 139
Study 32932369 — intervention group
Group type: COMPARATOR
Intervention: TECNIS Monofocal IOL (Model ZCB00)
Number of subjects: 139
Study 33274667 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 27
Study 33274667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 36270225 — intervention group
Group type: COMPARATOR
Intervention: Arms free
Number of subjects: 64
Study 36270225 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms constrained
Number of subjects: 64
Study 36270225 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral arm constrained
Number of subjects: 64
Study 36270225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral arm constrained
Number of subjects: 64
Study 33358073 — intervention group
Group type: EXPERIMENTAL
Intervention: Fugl-Meyer Assessment of Lower Extremity (FMA-LE) scored by three experienced physical therapists
Number of subjects: 60
Study 35664940 — intervention group
Group type: EXPERIMENTAL
Intervention: Acacia (Acacia nilotica Linn.) pod's sitz bath (30g) plus vaginal cotton pessary (5 ml) once daily for 10 days
Number of subjects: 66
Study 35664940 — intervention group
Group type: COMPARATOR
Intervention: Placebo (palm sugar powder 30g solution for sitz bath plus vaginal cotton pessary same as Acacia group)
Number of subjects: 66
Study 35664940 — intervention group
Group type: EXPERIMENTAL
Intervention: Acacia group
Number of subjects: 66
Study 32538007 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medication (levamlodipine maleate 2.5 mg once daily)
Number of subjects: 70
Study 32538007 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus western medication
Number of subjects: 70
Study 32538007 — intervention group
Group type: COMPARATOR
Intervention: Western medication (levamlodipine maleate 2.5 mg once daily)
Number of subjects: 70
Study 32538007 — intervention group
Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 70
Study 35324903 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of seasonal chocolate confectionery from prominent locations in intervention stores
Number of subjects: 185
Study 32719045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone (250 mg on day 1 followed by 80 mg on days 2-5) with or without tocilizumab (8 mg/kg body weight, single infusion) if respiratory condition did not improve sufficiently (in 43%).
Number of subjects: 172
Study 32719045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone with or without tocilizumab.
Number of subjects: 172
Study 32719045 — intervention group
Group type: COMPARATOR
Intervention: Supportive care only (historical control group).
Number of subjects: 172
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/day
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/three times-week
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/once a week
Number of subjects: 180
Study 34216815 — intervention group
Group type: COMPARATOR
Intervention: Control group (full dose arm)
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in Ki-67
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating sex hormones
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipokines
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid profile
Number of subjects: 180
Study 34216815 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin and glucose
Number of subjects: 180
Study 32664003 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing sertraline
Number of subjects: 1544
Study 32664003 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining sertraline with mirtazapine
Number of subjects: 1544
Study 32664003 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to mirtazapine after initial failure to remit on sertraline
Number of subjects: 1544
Study 35550149 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva microbiome α-diversity (Shannon index)
Number of subjects: 59
Study 35550149 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Veillonella nakazawae
Number of subjects: 59
Study 35550149 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut Bacteroides thetaiotaomicron
Number of subjects: 59
Study 35550149 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-chain fatty acid levels
Number of subjects: 59
Study 32984992 — intervention group
Group type: EXPERIMENTAL
Intervention: Concrete conceptualization of GMOs
Number of subjects: 1470
Study 32984992 — intervention group
Group type: COMPARATOR
Intervention: Abstract conceptualization of GMOs
Number of subjects: 1470
Study 32741031 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (775 patients, INR goal 2.5)
Number of subjects: 1097
Study 32741031 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation (322 patients)
Number of subjects: 1097
Study 36058900 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 450
Study 36058900 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous paravertebral block (PVB)
Number of subjects: 450
Study 36058900 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot intercostal nerve block (ICNB)
Number of subjects: 450
Study 36058900 — intervention group
Group type: COMPARATOR
Intervention: TEA
Number of subjects: 450
Study 36058900 — intervention group
Group type: EXPERIMENTAL
Intervention: PVB
Number of subjects: 450
Study 36058900 — intervention group
Group type: EXPERIMENTAL
Intervention: ICNB
Number of subjects: 450
Study 33405993 — intervention group
Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (0.2‐1.8 mg)
Number of subjects: 48
Study 33405993 — intervention group
Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (1.0 to 1.8 mg)
Number of subjects: 48
Study 33405993 — intervention group
Group type: EXPERIMENTAL
Intervention: TQ‐A3334 (1.2 mg) with food
Number of subjects: 48
Study 33554566 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vitamin-D levels (<50 nmol/L)
Number of subjects: 50
Study 33554566 — intervention group
Group type: COMPARATOR
Intervention: Normal vitamin-D levels (>50 nmol/L)
Number of subjects: 50
Study 34674368 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg time-release melatonin
Number of subjects: 580
Study 34674368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580
Study 34608842 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2940094
Number of subjects: 136
Study 34608842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 33028293 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced duration of antibiotic treatment
Number of subjects: 312
Study 33028293 — intervention group
Group type: COMPARATOR
Intervention: Standard duration of antibiotic treatment (control group)
Number of subjects: 312
Study 33028293 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker levels (CRP, PCT, proADM) measured at admission, day 5, and day 30
Number of subjects: 312
Study 35400033 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom based on micro-video class
Number of subjects: 2
Study 35400033 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching model
Number of subjects: 2
Study 34819131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (300 mg)
Number of subjects: 36
Study 34819131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32777692 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 508
Study 32777692 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone
Number of subjects: 508
Study 35716317 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss maintenance programme (WLM)
Number of subjects: 0
Study 32524888 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective replacement of peripheral intravenous cannula (72–96 h)
Number of subjects: 0
Study 32524888 — intervention group
Group type: COMPARATOR
Intervention: Standard replacement of peripheral intravenous cannula
Number of subjects: 0
Study 32524888 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective replacement of peripheral intravenous cannula
Number of subjects: 0
Study 32035412 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 202
Study 32035412 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study 36429385 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented reality exergame (Portable Exergame Platform for Elderly)
Number of subjects: 0
Study 36429385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer
Number of subjects: 0
Study 36429385 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 0
Study 33750673 — intervention group
Group type: EXPERIMENTAL
Intervention: aerobic and resistance training (MIX)
Number of subjects: 20
Study 33750673 — intervention group
Group type: COMPARATOR
Intervention: stretching (CON)
Number of subjects: 20
Study 36453237 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Vapor Therapy (Rezum procedure)
Number of subjects: 426
Study 33342254 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 302
Study 35507830 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based treatment for perfectionism
Number of subjects: 74
Study 35507830 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 74
Study 34275562 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine 20 mg every 8 hours for five days, then 20 mg daily for three months
Number of subjects: 77
Study 34275562 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 77
Study 34275562 — intervention group
Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 77
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional bike lanes
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Local roads with bicycle facilities
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Local roads without bicycle facilities or traffic calming
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Protected bike lanes with heavy separation
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Protected bike lanes with lighter separation (one way)
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Protected bike lanes with lighter separation (two way)
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of streetcar or train tracks
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill grades
Number of subjects: 604
Study 32388015 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary features blocking path
Number of subjects: 604
Study 35502024 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (aPRP) eye drop
Number of subjects: 61
Study 35502024 — intervention group
Group type: COMPARATOR
Intervention: Artificial tear (AT) eye drop
Number of subjects: 61
Study 32276515 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox Kinect training (3 times per week, 50 min per session for 10 weeks)
Number of subjects: 40
Study 32276515 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox Kinect training
Number of subjects: 40
Study 32276515 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintaining levels of physical activity)
Number of subjects: 40
Study 35970354 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiding Time (VT) in symptomatic men
Number of subjects: 30
Study 35970354 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiding Time (VT) sensitivity analysis
Number of subjects: 30
Study 35970354 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum flow rates (Qmax) in symptomatic men
Number of subjects: 30
Study 35970354 — intervention group
Group type: COMPARATOR
Intervention: Voiding Time (VT) vs Maximum flow rates (Qmax)
Number of subjects: 30
Study 32179132 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT plus hyperthermia (RCHT)
Number of subjects: 373
Study 32179132 — intervention group
Group type: COMPARATOR
Intervention: RCT
Number of subjects: 373